Curcumin Blocks Fn-Driven Esophageal Cancer (2026)
Curcumin blocks Fusobacterium nucleatum-driven esophageal squamous cell carcinoma by inhibiting the TLR4/MYD88/TRIF/STAT3 signaling axis, restoring chemotherapy sensitivity in preclinical models.
Evidence level: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Related signals
- Advances in targeted therapy for esophageal cancer
- A review of esophageal cancer research: emerging trends, progress and perspectives
- An esophageal cancer clinical trial - ES3
- Case Report: Small bowel metastasis from esophageal squamous cell carcinoma: a case series and systematic review of clinical characteristics, tropism, and survival outcomes
- Current landscape of immunotherapy in esophageal cancer: a literature review